Sign up to save your podcasts
Or
Share Updates on BTK Inhibitors and Multiple Sclerosis Trials - Part 2
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Updates on BTK Inhibitors and Multiple Sclerosis Trials - Part 2
In part two of this series, Drs. Shuvro Roy, Jiwon Oh, and Amit Bar-Or discuss the results of the FENhance 1 and 2 trials looking at fenebrutinib in relapsing MS.
For more information, please read about the abstract that was presented at the 2026 AAN Annual Meeting.
Read more about the Fenebrutinib Trial.
View all episodes
By American Academy of Neurology
4.8
132132 ratings
In part two of this series, Drs. Shuvro Roy, Jiwon Oh, and Amit Bar-Or discuss the results of the FENhance 1 and 2 trials looking at fenebrutinib in relapsing MS.
For more information, please read about the abstract that was presented at the 2026 AAN Annual Meeting.
Read more about the Fenebrutinib Trial.
More shows like Neurology Minute
View all
NEJM This Week
319 Listeners
JAMA Clinical Reviews
506 Listeners
Neurology® Podcast
298 Listeners
Practical Neurology Podcast
50 Listeners
Mayo Clinic Talks
299 Listeners
The Curbsiders Internal Medicine Podcast
3,360 Listeners
JAMA Neurology Author Interviews
13 Listeners
Core IM | Internal Medicine Podcast
1,152 Listeners
Neurology Today in 5
24 Listeners
Annals On Call Podcast
197 Listeners
JAMA Medical News
93 Listeners
The Clinical Problem Solvers
517 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
373 Listeners
Neurology Exam Prep Podcast
188 Listeners
Continuum Audio
84 Listeners